About
Research
Patient Care
Education
Community
HEAL Initiative Integrated Basic and Clinical Team-based Research in Pain (RM1 Clinical Trial Optional)
RFA-NS-22-069. Multiple application due dates. Expiration date March 12, 2024.
Transformative Educational Advancement and Mentoring Network (TEAM) (R25 Clinical Trial Not Allowed)
RFA-CA-23-013. Application due February 10, 2023.
Test Staff
TEST Event Time Zone & Calendar Features – DO NOT DELETE
this is a summary field.
2023 Basser Center for BRCA External Research Grant Program: Basser Innovation Award
LOI (required) due December 19, 2022. Full application deadline February 13, 2023.
The St. Baldrick’s Foundation-American Cancer Society Childhood Cancer Research
LOI (Required) Due December 5, 2022 (7:59 pm PST).
National Cancer Institute Youth Enjoy Science Research Education Program (R25 Clinical Trial Not Allowed)
RFA-CA-21-020. Applications Due September 28, 2023.
NCI Cancer Screening Research Network: ACCrual, Enrollment, and Screening Sites (ACCESS) Hub (UG1 Clinical Trial Required)
RFA-CA-23-020. Applications Due February 28, 2023.
Centers & Institutes
In partnership with the Cancer Center, the following Centers & Institutes help support our mission by bringing scientists and clinicians together to interact and collaborate around cancer research.
NCI Cancer Screening Research Network: Statistics and Data Management Center (UG1 Clinical Trial Required)
RFA-CA-23-021. Applications Due February 28, 2023.
NCI Cancer Screening Research Network: Coordinating and Communication Center (UG1 Clinical Trial Required)
RFA-CA-23-022. Applications Due February 28, 2023.
Notice of Special Interest: Administrative Supplements to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients and Scholars
NOT-OD-23-031 (NOSI). Application Due Date(s) – Submission dates vary by awarding IC
Notice of Special Interest (NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards
NOT-OD-23-032 (NOSI). Application Due Date(s) – Submission dates vary by awarding IC.
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
RFA-CA-23-002. Application Due Dates March 1, 2023 and September 1, 2023.
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
RFA-CA-23-003. Application Due Dates March 1, 2023 and September 1, 2023.
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
RFA-CA-23-004. Application Due Dates March 1, 2023 and September 1, 2023.
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
RFA-CA-23-005. Application Due Dates March 1, 2023 and September 1, 2023.
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)
RFA-CA-23-006. Revision applications due dates March 1, 2023 and September 1, 2023.
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)
RFA-CA-23-007. Revision applications due dates March 1, 2023 and September 1, 2023.
UCI Anti-Cancer Challenge Research
The UCI Anti-Cancer Challenge is a ride, run and walk aimed at raising awareness and funds for pilot studies and early-phase clinical trials that support cancer research at the UCI Chao Family Comprehensive Cancer Center.